Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen

NCT06641219 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancers

Interventions

DRUG: One single intravenous injection of [177Lu]Lu-BQ7876

Sponsor

Tomsk National Research Medical Center of the Russian Academy of Sciences